X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
cardiac & cardiovascular systems (26) 26
male (22) 22
female (21) 21
middle aged (21) 21
cardiovascular (20) 20
aged (19) 19
coronary heart disease (17) 17
index medicus (17) 17
risk factors (16) 16
acute coronary syndromes (11) 11
cardiac patients (11) 11
percutaneous coronary intervention (11) 11
cardiology (10) 10
heart attacks (10) 10
internal medicine (10) 10
risk (10) 10
mortality (9) 9
stroke (9) 9
transluminal angioplasty (8) 8
treatment outcome (8) 8
acute myocardial-infarction (7) 7
atrial fibrillation (7) 7
care and treatment (7) 7
diabetes (7) 7
patient outcomes (7) 7
abridged index medicus (6) 6
analysis (6) 6
angioplasty (6) 6
angioplasty, balloon, coronary (6) 6
cardiovascular disease (6) 6
biomarkers - blood (5) 5
cholesterol (5) 5
clinical competence (5) 5
coronary artery disease - therapy (5) 5
coronary disease (5) 5
coronary vessels (5) 5
genotype (5) 5
health risk assessment (5) 5
medical imaging (5) 5
myocardial infarction (5) 5
peripheral vascular disease (5) 5
predictive value of tests (5) 5
prospective studies (5) 5
quality assurance (5) 5
quality improvement (5) 5
risk assessment (5) 5
ablation (4) 4
accf/aha/acp clinical competence statement (4) 4
atherosclerosis (4) 4
atrial fibrillation - surgery (4) 4
cerebral infarction (4) 4
clinical outcomes (4) 4
fractional flow reserve (4) 4
hypertension (4) 4
incidence (4) 4
intervention (4) 4
ischemia (4) 4
medical colleges (4) 4
medical research (4) 4
medicine, experimental (4) 4
myocardial-infarction (4) 4
outcomes (4) 4
peer review, healthcare (4) 4
proportional hazards models (4) 4
pulmonary vein isolation (4) 4
trial (4) 4
aged, 80 and over (3) 3
alcohol septal ablation (3) 3
anemia (3) 3
angiography (3) 3
association (3) 3
atrial fibrillation - mortality (3) 3
balloon (3) 3
bleeding (3) 3
blockade (3) 3
c-reactive protein (3) 3
chronic kidney failure (3) 3
clinical competence - standards (3) 3
clinical trials (3) 3
clopidogrel (3) 3
comorbidity (3) 3
continuous quality improvement (3) 3
coronary angiography (3) 3
coronary artery disease - diagnosis (3) 3
diabetes mellitus (3) 3
dose-response relationship, drug (3) 3
double-blind method (3) 3
events (3) 3
expert consensus document (3) 3
heart (3) 3
heart attack (3) 3
heart-disease (3) 3
hematology (3) 3
impact (3) 3
in-hospital mortality (3) 3
inflammation (3) 3
inhibition (3) 3
kidney diseases (3) 3
management (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation, ISSN 0009-7322, 07/2013, Volume 128, Issue 4, pp. 436 - 472
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 08/2013, Volume 82, Issue 2, pp. E69 - E111
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 4, pp. 357 - 396
Journal Article
American Heart Journal, ISSN 0002-8703, 06/2017, Volume 188, pp. 73 - 81
We sought to determine the frequency of use and association between prasugrel and outcomes in acute coronary syndrome patients undergoing percutaneous coronary... 
CLAIMS DATA | TRIAL | CARDIAC & CARDIOVASCULAR SYSTEMS | INHIBITION | MANAGEMENT | RISK | THROMBOLYSIS | PATTERNS | TRITON-TIMI 38 | CYP2C19 | ELEVATION MYOCARDIAL-INFARCTION | Purinergic P2Y Receptor Antagonists - administration & dosage | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Male | Treatment Outcome | Ticlopidine - analogs & derivatives | Dose-Response Relationship, Drug | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Acute Coronary Syndrome - therapy | Cause of Death - trends | Female | Aged | Retrospective Studies | Prasugrel Hydrochloride - administration & dosage | Percutaneous Coronary Intervention | Preoperative Period | Transluminal angioplasty | Usage | Care and treatment | Coronary heart disease | Cardiac patients | Patient outcomes | Blood transfusion | Myocardial infarction | Performance evaluation | Intervention | Transfusion | Heart attacks | Angioplasty | Clinical trials | Prometheus | Bleeding | Blood | Risk factors | Data bases | Training | Ischemia | Risk assessment | Attenuation | Drug therapy | Age | Cerebral infarction | Adenosine | Stroke | Adjustment | Mortality | Regression | Risk analysis | Patients | Studies | Clopidogrel | Death | Infarction | Acute coronary syndromes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 1069 - 1069
  Background: GlycA, a novel marker of inflammation, has been associated with future CV risk among patients with or without pre-existing coronary artery... 
Cardiovascular | Internal Medicine | Angiography | Cardiac patients | Cardiovascular disease | Medical imaging | Health risk assessment | Collaboration
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2013, Volume 109, Issue 4, pp. 744 - 754
Summary Long-term (at least one year) dual anti-platelet therapy incorporating aspirin and clopidogrel is currently recommended following percutaneous coronary... 
New Technologies, Diagnostic Tools and Drugs | Pharmacogenetics | Antiplatelet agents | Cardiovascular risk | HEALTHY-SUBJECTS | GENOTYPE | THROMBOSIS | OF-FUNCTION POLYMORPHISM | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | METABOLISM | PERIPHERAL VASCULAR DISEASE | cardiovascular risk | OUTCOMES | HEMATOLOGY | ASSOCIATION | pharmacogenetics | PLATELET REACTIVITY | Myocardial Infarction - genetics | Myocardial Infarction - mortality | Ticlopidine - therapeutic use | Percutaneous Coronary Intervention - mortality | Coronary Thrombosis - genetics | Humans | Middle Aged | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Aryl Hydrocarbon Hydroxylases - genetics | Male | Prosthesis Design | Percutaneous Coronary Intervention - instrumentation | Time Factors | Coronary Thrombosis - prevention & control | Ticlopidine - metabolism | Female | Platelet Aggregation Inhibitors - metabolism | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Coronary Thrombosis - mortality | Drug-Eluting Stents | Genetic Predisposition to Disease | Risk Assessment | Gene Frequency | Risk Factors | Proportional Hazards Models | Treatment Outcome | Chi-Square Distribution | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Phenotype | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Cytochrome P-450 CYP2C19 | ATP Binding Cassette Transporter, Sub-Family B | Aged | Coronary Thrombosis - etiology | Myocardial Infarction - prevention & control | Polymorphism, Single Nucleotide | Percutaneous Coronary Intervention - adverse effects
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 13, pp. 162 - 162
  Methods Pts (N=2,848) of the Intermountain Heart Collaborative Study who underwent angiography for CAD determination and had lipoprotein particle and GlycA... 
Cardiovascular | Internal Medicine | Heart | Medicine, Experimental | Medical research | Angiography | Cardiac patients | Atoms & subatomic particles | Inflammation | Medical imaging | Collaboration | Clinical outcomes
Journal Article